Michael S. Turner Sells 5,232 Shares of 908 Devices Inc. (NASDAQ:MASS) Stock

908 Devices Inc. (NASDAQ:MASSGet Free Report) insider Michael S. Turner sold 5,232 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $6.99, for a total transaction of $36,571.68. Following the transaction, the insider now owns 9,105 shares in the company, valued at $63,643.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

908 Devices Trading Down 0.7 %

Shares of MASS stock opened at $7.16 on Friday. 908 Devices Inc. has a 1 year low of $4.85 and a 1 year high of $12.51. The firm’s 50 day moving average is $8.19 and its 200-day moving average is $7.08.

908 Devices (NASDAQ:MASSGet Free Report) last announced its earnings results on Tuesday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.08. 908 Devices had a negative net margin of 81.57% and a negative return on equity of 21.67%. The company had revenue of $14.30 million for the quarter, compared to analyst estimates of $13.45 million. During the same period in the prior year, the business earned ($0.20) earnings per share. 908 Devices’s quarterly revenue was down 9.5% on a year-over-year basis. Equities research analysts anticipate that 908 Devices Inc. will post -1.17 earnings per share for the current fiscal year.

Hedge Funds Weigh In On 908 Devices

Large investors have recently modified their holdings of the stock. Arete Wealth Advisors LLC raised its stake in shares of 908 Devices by 35.8% during the third quarter. Arete Wealth Advisors LLC now owns 22,758 shares of the company’s stock worth $152,000 after buying an additional 5,997 shares during the last quarter. Global Retirement Partners LLC bought a new stake in shares of 908 Devices during the third quarter worth approximately $62,000. ARK Investment Management LLC raised its stake in shares of 908 Devices by 1.0% during the third quarter. ARK Investment Management LLC now owns 4,013,460 shares of the company’s stock worth $26,730,000 after buying an additional 40,555 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of 908 Devices by 3.0% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 629,994 shares of the company’s stock worth $4,196,000 after buying an additional 18,492 shares during the last quarter. Finally, Daiwa Securities Group Inc. bought a new stake in shares of 908 Devices during the second quarter worth approximately $30,000. 65.74% of the stock is currently owned by institutional investors and hedge funds.

908 Devices Company Profile

(Get Free Report)

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.

Read More

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.